SciELO - Scientific Electronic Library Online

 
vol.84 issue4Growth in non-anemic infants supplemented with different prophylactic iron dosesSedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Jornal de Pediatria

Print version ISSN 0021-7557On-line version ISSN 1678-4782

Abstract

ANDRADE, Cláudia R. de; CAMARGOS, Paulo Augusto M.; IBIAPINA, Cássio da C.  and  LASMAR, Laura Maria de L. B. F.. Basal cortisol in asthmatics on two different doses of fluticasone propionate. J. Pediatr. (Rio J.) [online]. 2008, vol.84, n.4, pp.373-376. ISSN 0021-7557.  http://dx.doi.org/10.1590/S0021-75572008000400014.

OBJECTIVES: To evaluate basal plasma cortisol in persistent asthmatics on inhaled fluticasone propionate 200 mcg/day and 300 mcg/day. METHODS: Asthma diagnosis and classification was based on Global Initiative for Asthma recommendations. Patients aged 11 years old or less received fluticasone propionate 200 mcg/day and those older than 11 years received 300 mcg/day. After 10 weeks of treatment, plasma cortisol levels were monitored to evaluate the hypothalamic-pituitary-adrenal axis. RESULTS: Forty-one patients (65.9% males) aged 6 to 18 years old were evaluated. No statistical differences were found between plasma cortisol levels in patients who received 200 mcg/day (n = 13) and those who received 300 mcg/day (n = 28). CONCLUSIONS: Our results show that low and moderate doses of fluticasone propionate do not cause adrenal suppression.

Keywords : Asthma; cortisol; corticosteroids.

        · abstract in Portuguese     · text in English | Portuguese     · English ( pdf epdf ) | Portuguese ( pdf epdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License